Agilent Technologies: Business Model, SWOT Analysis, and Competitors 2026

Agilent Technologies, Inc. stands as a leading company in Healthcare. Generating $7.06 billion in annual revenue (growing 7.0% year-over-year) and carrying a market capitalization of $33.48 billion, the company has cemented its position as a foundational player in the global Diagnostics & Research landscape. Under the leadership of its leadership team, Agilent Technologies, Inc. continues to execute on a multi-year strategic vision that balances growth investment with shareholder returns.

This in-depth analysis examines Agilent Technologies, Inc.'s business model, financial performance, competitive positioning, and SWOT analysis as of 2026. Whether you're evaluating Agilent Technologies, Inc. as an investment, benchmarking it against peers, or researching its strategy, this guide covers the key factors that define Agilent Technologies, Inc.'s position in the Diagnostics & Research market today.

What You Will Learn

1. How Agilent Technologies, Inc. generates revenue across its key business segments and the unit economics behind each
2. A data-backed SWOT analysis covering Agilent Technologies, Inc.'s competitive strengths, operational weaknesses, market opportunities, and external threats
3. Who Agilent Technologies, Inc.'s main competitors are and how the company compares on key financial metrics
4. Agilent Technologies, Inc.'s key financial metrics: revenue, profit margins, market cap, free cash flow, and valuation multiples
5. Agilent Technologies, Inc.'s strategic direction and what to watch in 2026-2027

Key Takeaways

• Revenue: $7.06 billion annual revenue (TTM), +7.0% YoY
• Market Cap: $33.48 billion — one of the largest companies in the Healthcare sector
• Profitability: Gross margin 52.3%, operating margin 22.9%, net margin 18.3%
• Free Cash Flow: $847.12 million
• Return on Equity: 19.9% — strong
• Employees: 18,000 worldwide

Who Owns Agilent Technologies, Inc.?

Agilent Technologies, Inc. is publicly traded on the NYQ under the ticker symbol A. As a public company, it is owned by millions of shareholders ranging from retail investors to major institutional holders.

The largest shareholders of Agilent Technologies, Inc. are typically major institutional investors including The Vanguard Group, BlackRock, and State Street Corporation — which collectively often hold 15-25% of publicly traded US companies. Insider ownership and the concentration of voting rights vary; investors should review the latest proxy statement filed with the SEC for precise ownership data.

Agilent Technologies, Inc. has approximately 0.28 billion shares outstanding, with float shares of 0.00 billion — the freely tradeable portion. The stock trades at $118.11 per share as of early 2026.

Agilent Technologies, Inc.'s Mission Statement

Agilent Technologies, Inc.'s strategic mission is aligned with its core business activities in the Diagnostics & Research sector. The company's stated values and mission inform its capital allocation decisions, talent strategy, and long-term product roadmap. Mission statements for public companies are disclosed in annual reports and investor presentations — Agilent Technologies, Inc.'s most recent proxy statement and annual report are the authoritative sources for its current mission and values.

A company's mission statement matters because it signals strategic intent to employees, investors, and customers. For Agilent Technologies, Inc., the mission encompasses not just what the company does, but why it exists and how it creates value for stakeholders. Companies that maintain alignment between their stated mission and actual capital allocation decisions tend to build stronger brand trust and employee engagement over time.

In practice, Agilent Technologies, Inc.'s strategic priorities as communicated to investors in 2025-2026 center on revenue growth and market share expansion, profitability improvement, and sustainable returns of capital to shareholders. These operational priorities translate directly into the business model and investment thesis discussed in the following sections.

How Does Agilent Technologies, Inc. Make Money?

As of 2026, Agilent Technologies, Inc. generates $7.06 billion in annual revenue (growing 7.0% year-over-year), with a 52.3% gross margin and 22.9% operating margin. Market capitalization stands at $33.48 billion. Here is how the company generates its revenue:

Overview of Agilent Technologies Inc

Agilent Technologies Inc is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides innovative solutions to help researchers, scientists, and healthcare professionals make advancements in their respective fields. With a strong focus on precision and accuracy, Agilent has established itself as a trusted name in the industry.

Revenue Streams

Agilent Technologies Inc generates revenue through various channels, capitalizing on its diverse product portfolio and robust customer base. The company's primary revenue streams can be categorized as follows:

1. Instruments and Equipment Sales

Agilent manufactures and sells a wide range of advanced instruments and equipment used in laboratories and research facilities. These include analytical instruments, such as mass spectrometers, chromatographs, and spectroscopy systems. Agilent's instruments are known for their high performance, reliability, and accuracy, making them highly desirable among scientists and researchers worldwide.

2. Consumables and Supplies

In addition to instruments, Agilent also generates significant revenue from the sale of consumables and supplies. These include reagents, columns, sample preparation products, and other laboratory consumables that are essential for conducting experiments and analyses. Agilent's consumables are designed to work seamlessly with their instruments, ensuring optimal performance and precise results.

3. Services and Support

Agilent offers a comprehensive range of services and support to its customers. These services include instrument installation, calibration, maintenance, and repair. Additionally, the company provides training and consultancy services to help customers maximize the value and efficiency of their Agilent products. By offering excellent after-sales support, Agilent builds long-term relationships with its customers, fostering loyalty and repeat business.

4. Software and Informatics Solutions

Agilent recognizes the importance of data management and analysis in scientific research and diagnostics. To address this need, the company develops and sells software and informatics solutions that enable efficient data acquisition, processing, and interpretation. Agilent's software offerings include laboratory information management systems (LIMS), data analysis tools, and data integration platforms. These solutions enhance productivity and streamline

In 2026, management's strategic priorities center on operational efficiency, market share expansion, and disciplined capital allocation. Investors should review Agilent Technologies, Inc.'s latest annual report and quarterly earnings releases for the most current financial disclosures and strategic updates.

Agilent Technologies, Inc. Business Model Canvas

The Business Model Canvas framework provides a structured view of how Agilent Technologies, Inc. creates, delivers, and captures value.

Key Partners: Agilent Technologies, Inc.'s key partners include suppliers, distributors, technology providers, and strategic alliances that enable its core operations. In the Diagnostics & Research sector, these relationships provide supply chain resilience, expanded distribution, and access to complementary capabilities.

Key Activities: Agilent Technologies, Inc.'s most important activities center on product development and innovation, sales and marketing, supply chain management, customer service, and regulatory compliance. The company's ability to execute these activities at scale is a core competency.

Key Resources: Agilent Technologies, Inc.'s critical resources include its brand equity, intellectual property portfolio, customer relationships, human capital (18,000 employees), proprietary technology, and financial resources ($1.76B in cash).

Value Propositions: Agilent Technologies, Inc. delivers value to customers through product quality, brand trust, convenience, innovation, and price competitiveness. The specific value proposition varies by customer segment but consistently addresses core needs in the Diagnostics & Research market.

Customer Relationships: Agilent Technologies, Inc. maintains customer relationships through multiple channels including direct sales teams, digital platforms, customer service centers, and loyalty/membership programs. Customer retention is a key operational priority.

Channels: Agilent Technologies, Inc. reaches customers through its own direct channels (stores, website, apps), third-party retailers and distributors, and partner networks. The mix of direct vs. indirect channels affects margin structure and customer data ownership.

Customer Segments: Agilent Technologies, Inc. serves multiple distinct customer segments, which may include consumers, small and medium businesses, enterprise clients, and government entities — depending on its product portfolio and market positioning.

Cost Structure: Agilent Technologies, Inc.'s major costs include cost of goods sold (47.7% of revenue), research & development, sales & marketing, general & administrative expenses, and capital expenditures. Total operating costs represent 77.1% of revenue.

Revenue Streams: Agilent Technologies, Inc. generates revenue through its core product and service offerings.

Agilent Technologies, Inc. Competitors

Agilent Technologies, Inc.'s main competitors include Thermo Fisher Scientific Inc, Waters Corporation, PerkinElmer Inc, Shimadzu Corporation, Bruker Corporation. The company operates in the Diagnostics & Research segment of the Healthcare sector where competitive positioning is shaped by product quality, distribution scale, and brand strength.

Competitive Analysis

Agilent Technologies, Inc.'s competitive position in Diagnostics & Research is defined by its $33.48B market capitalization and 52.3% gross margins. Key competitive advantages include brand recognition and operational scale in the Diagnostics & Research market.

Agilent Technologies, Inc. SWOT Analysis

A SWOT analysis examines Agilent Technologies, Inc.'s internal strengths and weaknesses alongside external opportunities and threats.

Strengths

• Strong Margins: Agilent Technologies, Inc.'s gross margin of 52.3% is well above industry averages, reflecting pricing power, operational efficiency, or a high-value product mix. The operating margin of 22.9% demonstrates disciplined cost management even at scale.
• Capital Efficiency: A return on equity of 19.9% demonstrates that Agilent Technologies, Inc. generates strong returns from shareholder capital, a hallmark of companies with durable competitive advantages.

Weaknesses

• Leverage Risk: Agilent Technologies, Inc.'s debt-to-equity ratio of 51.4 indicates meaningful financial leverage. Total debt stands at $3.55B against $1.76B in cash and equivalents.

Opportunities

• Total Addressable Market: Agilent Technologies, Inc. operates in the Diagnostics & Research segment of the broader Healthcare sector, which represents a $12 trillion global healthcare market by 2030. Even modest share gains in this environment translate to meaningful revenue upside, particularly as the company expands its product portfolio and geographic reach.
• International Expansion: Emerging markets — particularly India (1.4B people, rapidly growing middle class), Southeast Asia (700M people), and Sub-Saharan Africa — represent significant untapped addressable markets for Agilent Technologies, Inc.'s products and services.
• Strategic Acquisitions: With $1.76B in cash and strong free cash flow generation, Agilent Technologies, Inc. is well-positioned to pursue strategic acquisitions that expand its capabilities, customer base, or geographic reach.

Threats

• Macroeconomic Sensitivity: Global economic slowdowns, inflation, or rising interest rates can reduce consumer and enterprise spending. Agilent Technologies, Inc.'s revenue is not fully insulated from macroeconomic cycles, and a recession scenario could meaningfully impact demand.
• Regulatory and Geopolitical Risk: Increasing government regulation — particularly data privacy laws (GDPR, CCPA), antitrust enforcement, and trade restrictions — poses compliance costs and potential restrictions on Agilent Technologies, Inc.'s business model across key markets.
• Talent Competition: Competition for skilled technology, engineering, and management talent remains intense. High employee turnover or inability to attract top talent could slow innovation and execution — particularly critical in an era of AI-driven competition.

Conclusion

Agilent Technologies, Inc. enters 2026 as a leading company in Healthcare, backed by $7.06 billion in annual revenue and a 18.3% net profit margin. The company's 52.3% gross margins and $847.12 million in free cash flow provide the financial foundation to fund growth initiatives while returning capital to shareholders.

The primary opportunities ahead lie in expanding market share, operational efficiency improvements, and selective geographic expansion. The key risks to monitor include competitive pressure from established peers and new entrants, macroeconomic headwinds, and regulatory developments in Agilent Technologies, Inc.'s core markets.

For investors, Agilent Technologies, Inc.'s 25.8x trailing P/E and 18.0x forward P/E reflect the market's expectations for stable earnings. Analysts and investors should watch quarterly earnings releases, management commentary on comparable sales growth, margin trends, and capital allocation for signals of how the investment thesis is progressing.

Data Sources

Financial data and business information for this analysis was sourced from: Yahoo Finance – Agilent Technologies, SEC EDGAR – Agilent Technologies Filings, and Agilent Technologies's investor relations materials.

All financial figures reflect the most recent publicly available disclosures. Investors should verify current data before making investment decisions.

Frequently Asked Questions

1. Who are Agilent's competitors?

Agilent Technologies, Inc. competes in the Diagnostics & Research segment of the Healthcare sector. The competitor comparison table in this article outlines key peers by market cap, revenue, and margins. Competitive dynamics in Diagnostics & Research center on product differentiation, pricing strategy, and distribution scale.

2. What kind of company is Agilent Technologies?

Agilent Technologies, Inc. generated $7.06 billion in annual revenue with a 18.3% net profit margin as of the latest reporting period. The company operates in the Diagnostics & Research sector. For the most current information, consult Agilent Technologies, Inc.'s investor relations page.

3. Is Agilent a Fortune 500 company?

Agilent Technologies, Inc. generated $7.06 billion in annual revenue with a 18.3% net profit margin as of the latest reporting period. The company operates in the Diagnostics & Research sector. For the most current information, consult Agilent Technologies, Inc.'s investor relations page.

4. What does Agilent Technologies, Inc. do?

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Ma

5. How much revenue does Agilent Technologies, Inc. make?

Agilent Technologies, Inc. generated $7.06 billion in annual revenue (TTM), with 7.0% year-over-year growth.

6. What is Agilent Technologies, Inc.'s market cap?

Agilent Technologies, Inc.'s market capitalization is approximately $33.48 billion as of early 2026.

7. Is Agilent Technologies, Inc. profitable?

Yes. Agilent Technologies, Inc. has a net profit margin of 18.3% and a return on equity of 19.9%.

8. Who are Agilent Technologies, Inc.'s competitors?

Agilent Technologies, Inc. competes in the Diagnostics & Research sector against companies including Thermo Fisher Scientific Inc, Waters Corporation, PerkinElmer Inc.

9. Does Agilent Technologies, Inc. pay dividends?

Yes, Agilent Technologies, Inc. pays a dividend with a current yield of approximately 85.0%.

10. What is Agilent Technologies, Inc.'s stock ticker?

Agilent Technologies, Inc. trades on the NYQ under the ticker symbol A.